Clinical Trial Update: Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating stress-dose hydrocortisone for coagulation dysfunction and hemodynamic effects in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Nanjing PLA General Hospital | Conditions: Coagulation Dysfunction in Septic Shock, Hemodynamic Improvement Induced by Hydrocortisone | Phase 3 | Status: COMPLETED